Johnson & Johnson's Q4: Looking Behind the Numbers
In earnings season, it's easy to focus on just whether a company beat or missed analyst expectations. But to get a true picture of how it did, it's important to dig down a bit into the financials to see just what drove results. Oftentimes, there are some key numbers that can help answer that question.
Healthcare giant Johnson & Johnson (NYSE: JNJ) released its fourth-quarter earnings last week. And while the headline will be that the company's sales rose 10% and earnings soared 173%, here are three key numbers investors need to look at to better understand the company's performance.
Image source: Getty Images.
Source Fool.com
